checkAd

     109  0 Kommentare Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30

    Financial filings are expected after market August 29, with a management conference call to follow the next day

    TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29, 2023. Entourage will host a conference call the following day on Wednesday, August 30, 2023, at 10 a.m. Eastern Time to review the results for the period and provide an operational update. 

    Conference Call Details:

    CEO and Executive Chair, George Scorsis and CFO, Vaani Maharaj will host the conference call. Management will be available for questions following the opening remarks. 

    Date:
    Wednesday, August 30, 2023

    Time:
    10 a.m. Eastern Time

    Dial-in Number:
    Canada/USA: 1-800-319-4610. 
    International Toll: 1-604-638-5340
    Participants, please dial in and ask to join the Entourage call

    Replay Dial-in:
    Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010
    Replay Access Code: 0350
    Available after 12:00 p.m. Eastern Time until September 30, 2023

    About Entourage Health Corp. 

    Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a fully licensed 26,000 sq. ft. Aylmer, ON processing facility. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multi-channelled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements Entourage’s direct sales to medical patients. Entourage’s elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and Syndicate Select – sold across eight provincial distribution agencies. Exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary’s Medicinals sold in both medical and adult-use channels. Under a collaboration with the Boston Beer Company, Entourage is also the exclusive distributor of cannabis-infused beverages ‘TeaPot’ in Canada.  In addition, Entourage also entered into an exclusive agreement with Irwin Naturals, a renowned nutraceutical and herbal supplement formulator of popular branded wellness products sold across North America.

    Seite 1 von 2



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30 Financial filings are expected after market August 29, with a management conference call to follow the next dayTORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) - Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a …